Takara Bio Inc. (TKBIF) Comparison with companies in other sectors?

Takara Bio Inc. has a share price of 120.42M. You can analyze Takara Bio Inc. (TKBIF) competitors across different market sectors through stock heatmaps.

What are TKBIF's NET and operating margins?

Takara Bio Inc. (TKBIF) operating margin is around N/A, and net profit margin is approximately N/A as of the latest reports.

In what way does TKBIF's earnings per share (EPS) trend reflect its financial momentum?

Takara Bio Inc. (TKBIF) EPS is -0.34 (If EPS value is positive, then "signals consistent profit growth" if Negative then "signals consistent loss"). This metric is also critical in assessing valuation metrics like the P/E ratio for Takara Bio Inc. is -21.47, and the company's ability to reinvest or distribute profits.

What does a high ROE mean for Takara Bio Inc.?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Takara Bio Inc. like P/E which is N/A, P/B which is N/A, and PEG which is N/A. Compare them with sector averages to evaluate if the stock is priced fairly.

Takara Bio Inc.

TKBIF•PNK

Healthcare

Biotechnology

$7.30

$0.00(0.00%)

U.S. Market opens in 8h 15m

Takara Bio Inc. Fundamental Analysis

Takara Bio Inc. (TKBIF) shows moderate financial fundamentals with a PE ratio of -21.47, profit margin of N/A, and ROE of N/A. The company generates N/A in annual revenue with moderate year-over-year growth of 3.53%.

Key Strengths

No significant strengths identified.

Areas of Concern

No major concerns flagged.

We analyze TKBIF's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 17.6/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

17.6/100

We analyze TKBIF's fundamental strength across five key dimensions:

Efficiency Score

Weak

TKBIF struggles to generate sufficient returns from assets.

ROA > 10%

N/A

Valuation Score

Moderate

TKBIF shows balanced valuation metrics.

PE < 25

-21.47

PEG Ratio < 2

N/A

Growth Score

Weak

TKBIF faces weak or negative growth trends.

Revenue Growth > 5%

3.53%

EPS Growth > 10%

-29.62%

Financial Health Score

Weak

TKBIF carries high financial risk with limited liquidity.

Debt/Equity < 1

N/A

Current Ratio > 1

N/A

Profitability Score

Weak

TKBIF struggles to sustain strong margins.

ROE > 15%

N/A

Net Margin ≥ 15%

N/A

Positive Free Cash Flow

N/A

Key Financial Metrics

Is TKBIF Expensive or Cheap?

P/E Ratio

TKBIF trades at -21.47 times earnings. This suggests potential undervaluation.

-21.47

How Well Does TKBIF Make Money?

No data available.

Following the Money - Real Cash Generation

No data available.

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

N/A

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

N/A

vs 25 benchmark

P/B Ratio

Price to book value ratio

N/A

vs 25 benchmark

P/S Ratio

Price to sales ratio

N/A

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

N/A

vs 25 benchmark

Current Ratio

Current assets to current liabilities

N/A

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

N/A

vs 25 benchmark

ROA

Return on assets percentage

N/A

vs 25 benchmark

ROCE

Return on capital employed

N/A

vs 25 benchmark

How TKBIF Stacks Against Its Sector Peers

Metric	TKBIF Value	Sector Average	Performance
P/E Ratio	N/A	29.45	N/A
ROE	N/A	779.00%	N/A
Net Margin	N/A	-24936.00% (disorted)	N/A
Debt/Equity	N/A	0.26	N/A
Current Ratio	N/A	4.65	N/A
ROA	N/A	-19344.00% (disorted)	N/A

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Takara Bio Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

30.30%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

-72.72%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

-7.81%

Industry Style: Defensive, Growth, Innovation

Declining

Takara Bio Inc. Fundamental Analysis

Key Strengths

Areas of Concern

Fundamental Health Score

Efficiency Score

Valuation Score

Growth Score

Financial Health Score

Profitability Score

Key Financial Metrics

Is TKBIF Expensive or Cheap?

How Well Does TKBIF Make Money?

Following the Money - Real Cash Generation

Financial Ratios Analysis

Valuation Ratios

Financial Health

Efficiency Ratios

How TKBIF Stacks Against Its Sector Peers

Historical Growth Performance

5-Year Growth Trajectory

Fundamental Analysis FAQ

Takara Bio Inc. (TKBIF) Comparison with companies in other sectors?

What are TKBIF's NET and operating margins?

In what way does TKBIF's earnings per share (EPS) trend reflect its financial momentum?

What does a high ROE mean for Takara Bio Inc.?

How do I know if AAPL is overvalued or undervalued?